PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAJ0. A total of 5 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,382,000 | -8.4% | 4,000,000 | 0.0% | 0.11% | -27.2% |
| Q2 2023 | $4,781,598 | +1.3% | 4,000,000 | 0.0% | 0.15% | +4.1% |
| Q1 2023 | $4,720,000 | -99.9% | 4,000,000 | 0.0% | 0.14% | +81.2% |
| Q3 2022 | $4,200,000,000 | 0.0% | 4,000,000 | 0.0% | 0.08% | +29.0% |
| Q2 2022 | $4,200,000,000 | +5.0% | 4,000,000 | 0.0% | 0.06% | +63.2% |
| Q4 2021 | $4,000,000,000 | 0.0% | 4,000,000 | 0.0% | 0.04% | +22.6% |
| Q3 2021 | $4,000,000,000 | – | 4,000,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITEBOX ADVISORS LLC | 5,000,000 | $6,134,923 | 0.21% |
| UBS OCONNOR LLC | 4,000,000 | $4,720,000 | 0.14% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 15,000,000 | $180 | 0.01% |
| CITIGROUP INC | 2,500,000 | $3,067,475 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |